This site uses cookies to provide you with a great user experience. By using BondbloX, you accept our use of cookies.

Piramal Finance Limited has received $148.1mn as deferred consideration from the earlier sale of Piramal Imaging SA, marking a major step in completing a divestment originally announced in 2018. The payment, received on 10 March 2026 through a subsidiary, forms part of the ongoing settlement linked to the sale of the step-down subsidiary to Alliance Medical Acquisitionco Limited. The original transaction involved Piramal Enterprises Limited, which has since merged with Piramal Finance Limited. Under the agreement, a portion of the consideration was structured as deferred payments tied to the future profitability of Piramal Imaging SA. With the latest payment, Piramal Finance has received a significant share of the potential proceeds. The maximum total consideration for the deal is capped at $200mn, leaving $51.9mn that may still be received in the coming years depending on eligible profits and earnouts. The company stated that the funds will be used to strengthen its balance sheet and enhance financial flexibility, supporting ongoing operations and growth initiatives.
Its 7.8% 2028s were stable at 101.8, yielding 6.77%
For more details, click here

